chr19-50416540-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002691.4(POLD1):​c.2953+12C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.636 in 1,549,824 control chromosomes in the GnomAD database, including 327,237 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.55 ( 25596 hom., cov: 34)
Exomes 𝑓: 0.65 ( 301641 hom. )

Consequence

POLD1
NM_002691.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.631
Variant links:
Genes affected
POLD1 (HGNC:9175): (DNA polymerase delta 1, catalytic subunit) This gene encodes the 125-kDa catalytic subunit of DNA polymerase delta. DNA polymerase delta possesses both polymerase and 3' to 5' exonuclease activity and plays a critical role in DNA replication and repair. Alternatively spliced transcript variants have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 6. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 19-50416540-C-T is Benign according to our data. Variant chr19-50416540-C-T is described in ClinVar as [Benign]. Clinvar id is 258788.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416540-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.682 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
POLD1NM_002691.4 linkuse as main transcriptc.2953+12C>T intron_variant ENST00000440232.7 NP_002682.2 P28340A0A024R4F4Q59FA0

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
POLD1ENST00000440232.7 linkuse as main transcriptc.2953+12C>T intron_variant 1 NM_002691.4 ENSP00000406046.1 P28340
ENSG00000142539ENST00000599632.1 linkuse as main transcriptc.160+12C>T intron_variant 5 ENSP00000473233.1 M0R3H8

Frequencies

GnomAD3 genomes
AF:
0.552
AC:
83965
AN:
152096
Hom.:
25590
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.329
Gnomad AMI
AF:
0.598
Gnomad AMR
AF:
0.643
Gnomad ASJ
AF:
0.509
Gnomad EAS
AF:
0.140
Gnomad SAS
AF:
0.439
Gnomad FIN
AF:
0.692
Gnomad MID
AF:
0.566
Gnomad NFE
AF:
0.687
Gnomad OTH
AF:
0.540
GnomAD3 exomes
AF:
0.582
AC:
89666
AN:
154134
Hom.:
28435
AF XY:
0.574
AC XY:
47665
AN XY:
83086
show subpopulations
Gnomad AFR exome
AF:
0.327
Gnomad AMR exome
AF:
0.702
Gnomad ASJ exome
AF:
0.516
Gnomad EAS exome
AF:
0.136
Gnomad SAS exome
AF:
0.449
Gnomad FIN exome
AF:
0.685
Gnomad NFE exome
AF:
0.686
Gnomad OTH exome
AF:
0.610
GnomAD4 exome
AF:
0.645
AC:
901856
AN:
1397608
Hom.:
301641
Cov.:
46
AF XY:
0.640
AC XY:
441424
AN XY:
690068
show subpopulations
Gnomad4 AFR exome
AF:
0.320
Gnomad4 AMR exome
AF:
0.697
Gnomad4 ASJ exome
AF:
0.514
Gnomad4 EAS exome
AF:
0.117
Gnomad4 SAS exome
AF:
0.453
Gnomad4 FIN exome
AF:
0.687
Gnomad4 NFE exome
AF:
0.690
Gnomad4 OTH exome
AF:
0.591
GnomAD4 genome
AF:
0.552
AC:
83985
AN:
152216
Hom.:
25596
Cov.:
34
AF XY:
0.550
AC XY:
40943
AN XY:
74428
show subpopulations
Gnomad4 AFR
AF:
0.328
Gnomad4 AMR
AF:
0.643
Gnomad4 ASJ
AF:
0.509
Gnomad4 EAS
AF:
0.140
Gnomad4 SAS
AF:
0.439
Gnomad4 FIN
AF:
0.692
Gnomad4 NFE
AF:
0.687
Gnomad4 OTH
AF:
0.535
Alfa
AF:
0.610
Hom.:
5292
Bravo
AF:
0.539
Asia WGS
AF:
0.301
AC:
1051
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 28, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -
Benign, criteria provided, single submitterclinical testingGeneDxNov 02, 2015This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJan 24, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 86% of patients studied by a panel of primary immunodeficiencies. Number of patients: 82. Only high quality variants are reported. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
not provided Benign:3
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 30, 2023- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 19, 2016Variant summary: The POLD1 c.2953+12C>T variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a benign outcome for this variant, and 5/5 Alamut algorithms predict not significant change to splicing. This variant was found in 13998/24162 control chromosomes (4157 homozygotes) at a frequency of 0.5793395, which is approximately 40785 times the estimated maximal expected allele frequency of a pathogenic POLD1 variant (0.0000142), highly suggesting this variant is a benign polymorphism. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as Benign. -
Colorectal cancer, susceptibility to, 10 Benign:2
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Mandibular hypoplasia-deafness-progeroid syndrome Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -
Hereditary cancer-predisposing syndrome Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 21, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.9
DANN
Benign
0.86
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3218776; hg19: chr19-50919797; COSMIC: COSV54532142; COSMIC: COSV54532142; API